IRIS Accounts Production v24.1.0.578 10390794 Board of Directors 1.10.23 6.9.24 6.9.24 false true false false false 248277 234279 31188 13998 279465 248277 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103907942023-09-30103907942024-09-06103907942023-10-012024-09-06103907942022-09-30103907942022-10-012023-09-30103907942023-09-3010390794ns15:EnglandWales2023-10-012024-09-0610390794ns14:PoundSterling2023-10-012024-09-0610390794ns10:Director12023-10-012024-09-0610390794ns10:PrivateLimitedCompanyLtd2023-10-012024-09-0610390794ns10:Micro-entities2023-10-012024-09-0610390794ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-0610390794ns10:FullAccounts2023-10-012024-09-061039079442ns10:Director22023-09-301039079442ns10:Director22022-09-301039079442ns10:Director22023-10-012024-09-061039079442ns10:Director22022-10-012023-09-301039079442ns10:Director22024-09-061039079442ns10:Director22023-09-3010390794ns5:CurrentFinancialInstruments2024-09-0610390794ns5:CurrentFinancialInstruments2023-09-3010390794ns10:RegisteredOffice2023-10-012024-09-0610390794ns10:Director22023-10-012024-09-06103907941ns10:Director12023-09-30103907941ns10:Director12022-09-30103907941ns10:Director12023-10-012024-09-06103907941ns10:Director12022-10-012023-09-30103907941ns10:Director12024-09-06103907941ns10:Director12023-09-30
REGISTERED NUMBER: 10390794 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 OCTOBER 2023 TO 6 SEPTEMBER 2024

FOR

360BIOMEDICAL LTD

360BIOMEDICAL LTD (REGISTERED NUMBER: 10390794)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 OCTOBER 2023 TO 6 SEPTEMBER 2024




Page

Balance Sheet 1


360BIOMEDICAL LTD (REGISTERED NUMBER: 10390794)

BALANCE SHEET
6 SEPTEMBER 2024

6.9.24 30.9.23
£    £   
FIXED ASSETS - 3,155

CURRENT ASSETS 374,370 346,561

CREDITORS
Amounts falling due within one year (17,081 ) (29,921 )
NET CURRENT ASSETS 357,289 316,640
TOTAL ASSETS LESS CURRENT
LIABILITIES

357,289

319,795

CAPITAL AND RESERVES 357,289 319,795

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

360Biomedical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10390794

Registered office: 11c Kings Parade
Cambridge
Cambridgeshire
CB2 1SJ

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 2 (2023 - 2 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 6 September 2024 and the year ended 30 September 2023:

6.9.24 30.9.23
£    £   
Dr R N Seabrook and Mrs A A Seabrook
Balance outstanding at start of period 248,277 234,279
Amounts advanced 31,188 13,998
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period 279,465 248,277

The directors were charged interest on the outstanding loan at the 'official rate'.

360BIOMEDICAL LTD (REGISTERED NUMBER: 10390794)

BALANCE SHEET - continued
6 SEPTEMBER 2024




The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 6 September 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 6 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 3 October 2024 and were signed on its behalf by:





Dr R N Seabrook - Director